887650-05-7,
Lyn-IN-1,
(S)-N-(3-(5,5'-Bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)-pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide,
N-[3-([5,5'-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide,
Q-101401,
(S)-N-(3-(5,5'-bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide,
4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(5-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide,
n-(3-((5,5'-bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3s)-3-(dimethylamino)-1-pyrrolidinyl)methyl)-3-(trifluoromethyl)benzamide,
Bafetinib(INNO-406),
Bafetinib(INNO-406)/,
SCHEMBL14698142,
QCR-131,
BCPP000355,
BCP01377,
KS-00000OP9,
ABP000609,
INNO-406, NS-187, Bafetinib,
ZINC70471841,
AKOS005145758,
AN-5366,
BCP9000374,
BCP9000375,
CS-0191,
RL05555,
NCGC00346514-01,
AC-26967,
HY-12039,
AB1008438,
FT-0774043,
SW220217-1,
X2632,
S-7804,
650B057,
4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-N-(4-methyl-3-{[5-(pyrimidin-5-yl)pyrimidin-2-yl]amino}phenyl)-3-(trifluoromethyl)benzamide,
Benzamide,N-[3-([5,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)-,
Bafetinib,
Bafetinib (INNO-406),
INNO-406,
cc-271,
C30H31F3N8O,
NS-187,
B1011,
859212-16-1,
4-[(s)-3-(dimethylamino)pyrrolidin-1-ylmethyl]-3-trifluoromethyl-n-{4-methyl-3-[4-(5-pyrimidinyl)pyrimidin-2-ylamino]phenyl}benzamide,
Benzamide, N-[3-([5,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)-,
N-(3-(((5,5'-Bipyrimidin)-2-yl)amino)-4-methylphenyl)-4-(((3S)-3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide,